Review



mab4101 sp c1q neutralizing antibody medchemexpress  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress mab4101 sp c1q neutralizing antibody medchemexpress
    Mab4101 Sp C1q Neutralizing Antibody Medchemexpress, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mab4101 sp c1q neutralizing antibody medchemexpress/product/MedChemExpress
    Average 93 stars, based on 3 article reviews
    mab4101 sp c1q neutralizing antibody medchemexpress - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    93
    MedChemExpress mab4101 sp c1q neutralizing antibody medchemexpress
    Mab4101 Sp C1q Neutralizing Antibody Medchemexpress, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mab4101 sp c1q neutralizing antibody medchemexpress/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    mab4101 sp c1q neutralizing antibody medchemexpress - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress hy p990545 critical
    Hy P990545 Critical, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hy p990545 critical/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    hy p990545 critical - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress anx005
    bEVs induced C1q‐mediated synaptic pruning through activating Piezo1. (A and B) Western blot and quantitative analysis demonstrate the protein levels of C1q in HMC3 cells treated with PBS or bEVs ( N = 3 independent rounds of experimentation. In each round, three wells of HMC3 cells per group were measured and averaged to generate a single data point). (C) qPCR results and quantitative analysis demonstrate mRNA levels of C1q and C3 in HMC3 cells treated with PBS or bEVs ( N = 5 independent rounds of experimentation. In each round, four wells of HMC3 cells per group were measured and averaged to generate a single data point). (D and E) Western blot and quantitative analysis demonstrate protein levels of C1q in the cortex and hippocampus of 2‐month‐old mice treated with PBS or bEVs via tail vein injection for 24 h ( N = 6 and 8 mice for PBS and bEVs groups respectively). (F and G) qPCR results and quantitative analysis demonstrate mRNA levels of C1q and C3 in the cortex and hippocampus of 2‐month‐old mice treated with or without bEVs via tail vein injection for 24 h ( N = 3 and 5 mice for PBS and bEVs group, respectively). (H and I) Western blot and quantitative analysis demonstrate protein level of C1q in the hippocampus of 2‐month‐old mice treated with PBS, Pxb, bEVs, or bEVs+PxB via brain stereotactic injection for 24 h ( N = 3 mice in each group). (J and K) Representative immunofluorescence images and quantitative analysis show the presence of synaptic puncta (PSD95+) in a primary neuron and microglia cocultured system, and coculture cells were pretreated with <t>ANX005</t> for 1 h, followed by treatment with PBS or bEVs ( N = 3 independent rounds of experimentation, each using primary neurons and microglia isolated from five different neonatal mice. In each round, six randomly captured neurons per well were measured and averaged to generate a single data point). (L and M) Western blot and quantitative analysis demonstrate protein levels of C1q in HMC3 cells pretreated with or without 5 µM GsMTx4 for 1 h, followed by bEV treatment ( N = 3 round of experimentation. In each round, four wells of HMC3 cells per group were measured and averaged to generate a single data point). Scale bar: 10 µm for J. Values are means ± SEM. ns, not significant; * p < .05. bEV, bacterial extracellular vesicle; PxB, polymyxin B.
    Anx005, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anx005/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    anx005 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    Image Search Results


    bEVs induced C1q‐mediated synaptic pruning through activating Piezo1. (A and B) Western blot and quantitative analysis demonstrate the protein levels of C1q in HMC3 cells treated with PBS or bEVs ( N = 3 independent rounds of experimentation. In each round, three wells of HMC3 cells per group were measured and averaged to generate a single data point). (C) qPCR results and quantitative analysis demonstrate mRNA levels of C1q and C3 in HMC3 cells treated with PBS or bEVs ( N = 5 independent rounds of experimentation. In each round, four wells of HMC3 cells per group were measured and averaged to generate a single data point). (D and E) Western blot and quantitative analysis demonstrate protein levels of C1q in the cortex and hippocampus of 2‐month‐old mice treated with PBS or bEVs via tail vein injection for 24 h ( N = 6 and 8 mice for PBS and bEVs groups respectively). (F and G) qPCR results and quantitative analysis demonstrate mRNA levels of C1q and C3 in the cortex and hippocampus of 2‐month‐old mice treated with or without bEVs via tail vein injection for 24 h ( N = 3 and 5 mice for PBS and bEVs group, respectively). (H and I) Western blot and quantitative analysis demonstrate protein level of C1q in the hippocampus of 2‐month‐old mice treated with PBS, Pxb, bEVs, or bEVs+PxB via brain stereotactic injection for 24 h ( N = 3 mice in each group). (J and K) Representative immunofluorescence images and quantitative analysis show the presence of synaptic puncta (PSD95+) in a primary neuron and microglia cocultured system, and coculture cells were pretreated with ANX005 for 1 h, followed by treatment with PBS or bEVs ( N = 3 independent rounds of experimentation, each using primary neurons and microglia isolated from five different neonatal mice. In each round, six randomly captured neurons per well were measured and averaged to generate a single data point). (L and M) Western blot and quantitative analysis demonstrate protein levels of C1q in HMC3 cells pretreated with or without 5 µM GsMTx4 for 1 h, followed by bEV treatment ( N = 3 round of experimentation. In each round, four wells of HMC3 cells per group were measured and averaged to generate a single data point). Scale bar: 10 µm for J. Values are means ± SEM. ns, not significant; * p < .05. bEV, bacterial extracellular vesicle; PxB, polymyxin B.

    Journal: Alzheimer's & Dementia

    Article Title: Gut‐derived bacterial vesicles carrying lipopolysaccharide promote microglia‐mediated synaptic pruning

    doi: 10.1002/alz.70331

    Figure Lengend Snippet: bEVs induced C1q‐mediated synaptic pruning through activating Piezo1. (A and B) Western blot and quantitative analysis demonstrate the protein levels of C1q in HMC3 cells treated with PBS or bEVs ( N = 3 independent rounds of experimentation. In each round, three wells of HMC3 cells per group were measured and averaged to generate a single data point). (C) qPCR results and quantitative analysis demonstrate mRNA levels of C1q and C3 in HMC3 cells treated with PBS or bEVs ( N = 5 independent rounds of experimentation. In each round, four wells of HMC3 cells per group were measured and averaged to generate a single data point). (D and E) Western blot and quantitative analysis demonstrate protein levels of C1q in the cortex and hippocampus of 2‐month‐old mice treated with PBS or bEVs via tail vein injection for 24 h ( N = 6 and 8 mice for PBS and bEVs groups respectively). (F and G) qPCR results and quantitative analysis demonstrate mRNA levels of C1q and C3 in the cortex and hippocampus of 2‐month‐old mice treated with or without bEVs via tail vein injection for 24 h ( N = 3 and 5 mice for PBS and bEVs group, respectively). (H and I) Western blot and quantitative analysis demonstrate protein level of C1q in the hippocampus of 2‐month‐old mice treated with PBS, Pxb, bEVs, or bEVs+PxB via brain stereotactic injection for 24 h ( N = 3 mice in each group). (J and K) Representative immunofluorescence images and quantitative analysis show the presence of synaptic puncta (PSD95+) in a primary neuron and microglia cocultured system, and coculture cells were pretreated with ANX005 for 1 h, followed by treatment with PBS or bEVs ( N = 3 independent rounds of experimentation, each using primary neurons and microglia isolated from five different neonatal mice. In each round, six randomly captured neurons per well were measured and averaged to generate a single data point). (L and M) Western blot and quantitative analysis demonstrate protein levels of C1q in HMC3 cells pretreated with or without 5 µM GsMTx4 for 1 h, followed by bEV treatment ( N = 3 round of experimentation. In each round, four wells of HMC3 cells per group were measured and averaged to generate a single data point). Scale bar: 10 µm for J. Values are means ± SEM. ns, not significant; * p < .05. bEV, bacterial extracellular vesicle; PxB, polymyxin B.

    Article Snippet: The cells were pretreated with 1 ng/mL ANX005 (HY‐P990545, MCE, USA), a humanized recombinant antibody against C1q, for 1 h to inhibit the complement cascade.

    Techniques: Western Blot, Injection, Immunofluorescence, Isolation